Table 4.
Adverse events | Grade 1-2 | Grade 3 | ||||
---|---|---|---|---|---|---|
Control group | Study group | Control group | Study group | Total (%) | ||
Oral ulcers | 3 | 2 | 0 | 0 | 5 (7.6%) | |
Rash | 8 | 7 | 0 | 0 | 15 (22.1%) | |
Diarrhea | 1 | 4 | 1 | 0 | 6 (8.8%) | |
Nausea | 1 | 3 | 2 | 0 | 6 (8.8%) | |
Myelosuppression | 3 | 9 | 0 | 7 | 19 (27.9%) | |
Hepatotoxicity | 0 | 6 | 0 | 0 | 6 (8.8%) | |
increased CK | 5 | 7 | 0 | 0 | 12 (17.6%) | |
Fatigue | 1 | 2 | 0 | 0 | 3 (4.4%) | |
Decreased appetite | 1 | 4 | 0 | 0 | 5 (7.4%) |